Attached files
| file | filename |
|---|---|
| 10-K - 10-K - Tracon Pharmaceuticals, Inc. | tcon-10k_20161231.htm |
| EX-32.2 - EX-32.2 - Tracon Pharmaceuticals, Inc. | tcon-ex322_726.htm |
| EX-32.1 - EX-32.1 - Tracon Pharmaceuticals, Inc. | tcon-ex321_727.htm |
| EX-31.2 - EX-31.2 - Tracon Pharmaceuticals, Inc. | tcon-ex312_725.htm |
| EX-31.1 - EX-31.1 - Tracon Pharmaceuticals, Inc. | tcon-ex311_724.htm |
| EX-10.12 - EX-10.12 - Tracon Pharmaceuticals, Inc. | tcon-ex1012_1067.htm |
| EX-10.10 - EX-10.10 - Tracon Pharmaceuticals, Inc. | tcon-ex1010_1066.htm |
| EX-10.9 - EX-10.9 - Tracon Pharmaceuticals, Inc. | tcon-ex109_1065.htm |
| EX-10.8 - EX-10.8 - Tracon Pharmaceuticals, Inc. | tcon-ex108_1064.htm |
| EX-10.7 - EX-10.7 - Tracon Pharmaceuticals, Inc. | tcon-ex107_1063.htm |
| EX-10.6 - EX-10.6 - Tracon Pharmaceuticals, Inc. | tcon-ex106_728.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements:
|
|
|
|
(1)Registration Statement (Form S-8 No. 333-201808) pertaining to the 2011 Equity Incentive Plan, 2015 Equity Incentive Plan, and 2015 Employee Stock Purchase Plan of TRACON Pharmaceuticals, Inc., and |
|
|
|
|
(2)Registration Statement (Form S-3 No. 333-209313) of TRACON Pharmaceuticals, Inc.; |
of our report dated February 28, 2017, with respect to the consolidated financial statements of TRACON Pharmaceuticals, Inc. included in its Annual Report (Form 10-K) for the year ended December 31, 2016, filed with the Securities and Exchange Commission.
|
|
/s/ Ernst & Young LLP |
San Diego, California
February 28, 2017